Thermo Fisher's 3.12% Surge on Strategic Shifts, 150th in $740M Daily Trading Volume

. 11, 2025, , . The biotech giant’s performance followed a strategic update highlighting expanded R&D partnerships and supply chain optimization initiatives. Analysts noted the move reflected investor confidence in TMO’s long-term growth trajectory amid a competitive market landscape.

. Management emphasized maintaining a disciplined approach to cost management, which has historically supported consistent cash flow generation. .

To run this back-test accurately I need to make sure we are using the right data universe and definitions. A few points to confirm before I start pulling data and coding the daily re-balances: 1. , ? • ADRs, ? 2. ? ? 3. . Our current data interface can handle that, but it’s a heavy call, so I want to be sure the definition above is exactly what you have in mind before I proceed. . . . . Let me know your preferences on the three points above and I’ll start the data run right away.